Theme news

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced a new strategic collaboration with Broad Clinical Labs, aiming to accelerate the adoption of its next-generation Sequencing by Expansion (SBX) technology, with an initial focus on trio-based whole genome sequencing for critically ill newborns and their biological parents. The partnership signifies a pivotal move in expanding genomics-enabled healthcare and precision medicine at scale.

This joint initiative is poised to establish SBX as a clinical mainstay in neonatal intensive care units (NICUs), helping identify genetic disorders in newborns with unprecedented speed and precision. It also positions both organizations to lead in delivering fast, scalable, and cost-efficient genomic insights that could redefine diagnostic and therapeutic practices.

Targeting Transformational Impact in Clinical Genomics

SHERIDAN, WYOMING – May 27, 2025 – Roche has unveiled compelling two-year follow-up data from its pivotal phase III STARGLO trial, reinforcing the long-term clinical value of Columvi® (glofitamab) in combination with chemotherapy for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). The results underscore the strategic impact of Roche’s bispecific antibody pipeline in addressing aggressive hematologic malignancies with limited treatment options.

Landmark Survival Benefit in R/R DLBCL

The updated STARGLO data show a 40% improvement in overall survival for patients treated with Columvi plus GemOx (gemcitabine and oxaliplatin), compared to the control arm receiving MabThera®/Rituxan® (rituximab) with GemOx. Notably, the median overall survival for the Columvi arm was not reached, versus 13.5 months in the comparator group.

Further findings demonstrated:

SHERIDAN, WYOMING – May 27, 2025 – Roche has received FDA approval for Susvimo® (ranibizumab injection) 100 mg/mL as a new treatment for diabetic retinopathy (DR), marking a pivotal advancement in the battle against this vision-threatening condition that affects nearly 10 million Americans.

The approval makes Susvimo the first and only FDA-approved continuous drug delivery system for DR, offering patients the potential to maintain vision with just one refill every nine months. This development adds a third approved indication for Susvimo, which is already cleared for neovascular or ‘wet’ age-related macular degeneration and diabetic macular edema.

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced an encouraging update on its supplemental Biologics License Application (sBLA) for Columvi® (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx), following discussion by the FDA’s Oncologic Drugs Advisory Committee (ODAC). The combination therapy demonstrated a significant 41% reduction in the risk of death in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) who are not candidates for autologous stem cell transplant.

Landmark survival data in STARGLO trial supports regulatory momentum

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced FDA approval of its VENTANA® MET (SP44) RxDx Assay, marking a major milestone in companion diagnostics for non-small cell lung cancer (NSCLC). This approval paves the way for a more precise identification of patients eligible for AbbVie’s Emrelis™ (telisotuzumab vedotin-tllv), a targeted therapy for non-squamous NSCLC with MET protein overexpression.

Enhancing Treatment Precision in Lung Cancer Care

The VENTANA MET (SP44) RxDx Assay is the first FDA-approved companion diagnostic for detecting MET protein expression in NSQ-NSCLC patients. By identifying those with elevated levels of MET—a key predictive biomarker—the assay supports clinicians in selecting patients who are most likely to benefit from c-Met-targeted therapy.

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced compelling final results from the decade-long APHINITY Phase III clinical trial, demonstrating a significant 17% reduction in the risk of death for patients with HER2-positive early-stage breast cancer who received a Perjeta® (pertuzumab)-based adjuvant therapy. These findings reinforce the strategic role of the Perjeta-based regimen in long-term disease management and will be presented as a late-breaking abstract at the 2025 ESMO Breast Cancer Congress.

Strategic Impact for High-Risk Patient Groups

The APHINITY study highlights even stronger benefits in a key subgroup: patients with lymph node-positive disease experienced a 21% reduction in mortality risk. This outcome strengthens the treatment’s position in clinical practice, especially for those at heightened risk of recurrence.

SHERIDAN, WYOMING – May 27, 2025 – Roche has introduced its Elecsys® PRO-C3 diagnostic test, marking a major step forward in the assessment of liver fibrosis severity, particularly in patients with metabolic dysfunction–associated steatotic liver disease (MASLD). With the ability to deliver results in just 18 minutes, the new test is poised to streamline diagnostics and enable earlier, more accurate clinical decision-making.

Strategic Response to a Global Health Burden

MASLD, affecting approximately 30% of the global population, is increasingly prevalent due to rising rates of diabetes, obesity, and other cardiometabolic risk factors. While it contributes to around one in every 25 deaths globally, liver fibrosis associated with MASLD often progresses unnoticed until late stages, escalating risks of cirrhosis, liver failure, and cancer.

SHERIDAN, WYOMING – May 27, 2025 – ANGA COM, Europe’s premier business platform for broadband, television, and online media, is set to return from June 3 to 5, 2025, in Cologne, Germany, with a bold agenda designed to shape the future of digital infrastructure and content delivery across Europe and beyond.

With more than 480 exhibitors from 35 countries and over 23,000 participants expected, ANGA COM 2025 underscores its strategic importance as a hub for the broadband and media sectors. Anchored in the economic heart of Germany’s telecommunications industry, the event offers a dynamic meeting point for network operators, technology providers, and media stakeholders to forge partnerships, showcase innovation, and debate key industry trends.

A powerhouse gathering for broadband and content leaders

SHERIDAN, WYOMING – May 27, 2025 – Hettich is redefining the digital landscape of furniture manufacturing with the introduction of intuitive assembly technologies showcased at interzum 2025. The fittings specialist is highlighting its latest advancements in user-friendly digital tools—from augmented reality and QR code guidance to a debut 3D printing portal—designed to streamline operations and enhance productivity across workshops and production facilities.

Empowering Workflows Through Digital Innovation

Hettich’s interzum 2025 presence is centered on supporting modern fabricators with practical, mobile-enabled digital services. Built on a “Bring your own device” model, these tools grant instant access to step-by-step instructions, adjustment aids, and training videos through smartphones or tablets.

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of space utilization with its award-winning SpinLines product family—a transformative suite of turning swivel systems designed to revolutionize how furniture and interiors function. Debuted in phases since 2019 and spotlighted at interzum 2023 and 2025, these innovative solutions enable unprecedented flexibility in residential and commercial design, offering new avenues for architects, fabricators, and furniture manufacturers.

From Turntable to Room Transformation

The journey began with a vision: rethinking how storage space is accessed and used. In collaboration with Chemnitz-based “WIRfinder” innovation network, Hettich developed the prototype ComfortSpin—a turntable that rotates cabinet or refrigerator contents to the front for easy access. The concept, rooted in translatory rotation, quickly gained traction among kitchen appliance makers and entered mass production in 2019.

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of workspace design with its latest innovations unveiled at interzum 2025. Under the theme “Transforming Spaces – with innovative motion,” the company presents RoomSpin and SpinLines—modular systems that bring motion, flexibility, and architectural intelligence to contract furnishing.

At its “Space and Architecture” exhibit, Hettich introduces a holistic concept for rethinking how rooms and furniture function, offering transformative solutions for compact living, open-plan environments, public spaces, and retail. The focus: adaptive interiors guided by choreographed movement.

Agile Planning for Dynamic Environments

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reaffirming its role as a global innovation leader in furniture fittings at interzum 2025, unveiling a strategically aligned portfolio that meets the evolving demands of trade professionals, furniture retailers, and manufacturers. The new offerings reflect a forward-looking vision centered on user convenience, functional performance, and market adaptability—spanning living, kitchen, workspace, and outdoor applications.

Elegant Innovation: Avosys Glass and Mirror Door Hinge

Designed for premium aesthetic integration, the new Avosys hinge delivers a discreet, high-performance solution for glass and mirror cabinets. With its sleek, compact design and narrow linear mounting plate, Avosys prioritizes interior space without compromising strength.

SHERIDAN, WYOMING – May 27, 2025 – Hettich, one of the world’s leading manufacturers of furniture fittings, is poised to reshape the future of interiors with its cutting-edge innovations and sustainability-driven initiatives showcased at interzum 2025. Under the visionary theme “Transforming Spaces – with innovative motion,” the company brings forward a portfolio that highlights its commitment to customer-centric design, strategic industry collaboration, and environmentally responsible business practices.

Expanding Innovation with Strategic Product Highlights

At the forefront of Hettich’s interzum 2025 presentation are several groundbreaking product introductions designed to enhance user experience, optimize space utilization, and support evolving industry demands:

SHERIDAN, WYOMING – May 27, 2025 – Ninkaplast GmbH (Ninka), a leading German supplier of injection-molded components for kitchen furniture, unveiled key product innovations at Interzum 2025 with the expansion of its modular waste bin systems, designed for under-sink installation and seamless integration into modern kitchen drawers.

With the debut of expanded variants in the “one2seven,” “one2eight,” and “one2nine” product lines, Ninka strengthens its value proposition for kitchen manufacturers seeking differentiation, operational flexibility, and improved consumer convenience. These developments highlight Ninka’s commitment to intelligent system design and compatibility across multiple drawer platforms.

Strategic Differentiation Through Flexible System Architecture

SHERIDAN, WYOMING – May 27, 2025 – At Interzum 2025, Ninkaplast GmbH (Ninka) presented a bold redefinition of corner storage functionality, blending advanced plastic moulding with rising market demands for individualization and sustainability. With its two flagship solutions, Trigon 2.0 and Qanto, the German-based family enterprise underscored its commitment to functional excellence and environmental accountability in kitchen design and beyond.

Transforming Corner Units into Efficient, Accessible Storage

Traditionally underutilized, corner cabinets are being reimagined by Ninka as high-performance, user-centric zones within the kitchen landscape. The Trigon system, long known for its turn-and-slide shelving mechanism, has been newly optimized for Interzum 2025. It supports up to 25 kg per shelf and integrates seamlessly into various cabinet sizes, including end units.

Key upgrades to Trigon 2.0 include:

SHERIDAN, WYOMING – May 27, 2025 – Ninkaplast GmbH, a leading German manufacturer of injection-molded plastic components for the kitchen and furniture industry, has marked a strategic milestone at Interzum 2025 by relaunching its iconic kitchen scoop under the new name "Konda" and unveiling an expanded line-up of its highly popular “cuisio” drawer organizers.

These launches underscore Ninka’s continued investment in ergonomic design, modularity, and functional aesthetics, all while meeting growing global demand for space-saving and sustainable kitchen solutions.

‘Konda’: A Smart Return to Functional Roots

Seventy years after introducing the original kitchen scoop, Ninka returns to its heritage with a completely redesigned product that reflects the evolving needs of today’s households. "Konda" is more than a storage container — it is a compact, ergonomic, and sustainable solution tailored to the rhythm of modern kitchens.

SHERIDAN, WYOMING – May 27, 2025 – At Interzum 2025 in Cologne, Ninka underscored its position as a strategic partner for kitchen furniture manufacturers and hardware wholesalers by showcasing its flexible, customer-centric cabinet interior solutions under the brand message “My Ninka.” With a clear focus on product personalization, the company delivered a compelling demonstration of how design, function, and individuality can converge to create added value across the kitchen furniture supply chain.

Strategic Emphasis on Tailored Simplicity

Ninka, officially known as Ninkaplast GmbH, is leveraging nearly a century of expertise in plastic molding and surface finishing to address the growing demand for customization in kitchen cabinet interiors. At its Interzum booth (B038 in Hall 7.1), Ninka structured its presentation around three key product segments:

SHERIDAN, WYOMING – May 23, 2025 – LAMILUX Heinrich Strunz GmbH, a European leader in daylight systems and composite solutions, has received the prestigious intermedia-globe Silver Award at the 26th WorldMediaFestival in Berlin for its cinematic brand film “Wir leben Tageslicht.” This international recognition underscores LAMILUX’s strategic emphasis on brand storytelling, innovation, and emotional connectivity in corporate communications.

Award-Winning Communication Strategy

The award was presented in the highly competitive “Corporate Communications – Corporate Image” category, honoring LAMILUX’s outstanding visual and emotional portrayal of its brand philosophy. Among 764 global submissions spanning 29 countries, the jury praised the film as an exemplary case of emotionally resonant storytelling and architectural clarity.

SHERIDAN, WYOMING – May 23, 2025 – In the heart of Germany’s Breisgau region, a pioneering business facility is setting new standards in architectural efficiency, work environment quality, and natural lighting integration. The newly inaugurated Kompetenzzentrum Breisgau in Eschbach features the advanced LAMILUX Glass Roof PR60, placing both aesthetic and functional innovation at the center of a transformative workspace concept.

Strategic Location Meets Forward-Thinking Design

Located near Freiburg and bordering Switzerland and the Alsace region, the Breisgau Competence Center is strategically positioned to attract both regional enterprises and international collaborators. The facility spans approximately 4,000 square meters and includes:

SHERIDAN, WYOMING – May 19, 2025 – EGGER, a global leader in wood-based materials, will showcase its latest product innovations, design surfaces, and sustainability initiatives under the theme “Inspire. Grow. Create.” at interzum 2025 in Cologne, Germany. The event, taking place from May 20 to 23, marks a strategic opportunity for the company to highlight its role in shaping the future of interior design and furniture manufacturing.

A Strategic Platform for Innovation and Growth